Impressive progress in biotechnology research and further understanding of cancer pathophysiology has led to the development of new, practical, and innovative drugs through collaborations in multidisciplinary fields including biology, drug metabolism, clinical research, medicinal chemistry, and computational chemistry.
We provide a list of different biologicals or drugs that are in recent Phase 3/4 cancer clinical trials.